Image Not FoundImage Not Found

Emerging Tech

Vylor Starts Trading After Corteva Spinout, Putting Seed Genetics to the Standalone Test

Corteva has completed the 1:1 spinout of Vylor, creating a pure-play seed and genetics company on the NYSE.…

ByByAva Davis Oct 1, 2026

AstraZeneca’s $2 Billion Summit Deal Buys Oncology Optionality, Not Proof

AstraZeneca is investing $2 billion in Summit Therapeutics and launching a trial collaboration around ivonescimab and Sone-Ve. The…

ByByKen Avery Sep 30, 2026

Fervo Energy’s Cape Station Achieves First Power, Testing Whether Enhanced Geothermal Can Scale

Fervo synchronized and exported electricity from the first 33-megawatt unit at Cape Station in Utah, a milestone for…

ByByKen Avery Sep 28, 2026

Anthropic says Claude found a novel enzyme system with CRISPR-like repeats

Anthropic’s first public life-sciences result suggests AI agents can materially compress genomic search and candidate triage. But the…

ByByMichael Smith Sep 26, 2026
Image Not Found

Archer clears HSR waiting-period hurdle for Boeing’s Wisk, Insitu and SkyGrid deal

Archer’s proposed acquisition of Boeing’s autonomy and drone subsidiaries has cleared a key antitrust waiting-period step, but the…

ByByJuan Martinez Sep 24, 2026

TEKEVER’s $580 Million Series D Puts Europe’s Defense-Tech Scale-Up Model on Trial

TEKEVER says it has reached a first close of $580 million at a $6.4 billion valuation, days after…

ByByKen Avery Sep 24, 2026